First American Trust, Fsb Biogen Inc. Transaction History

First American Trust, Fsb

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 08, 2019	SELL	$219.29 - $241.72 $2.54 Million - $2.8 Million	-11,567 Closed	0 $0
Q1 2019 Apr 09, 2019	BUY	$216.71 - $338.96 $51,143 - $79,994	236 Added 2.08%	11,567 $2.73 Million
Q4 2018 Jan 11, 2019	SELL	$278.5 - $352.75 $58,763 - $74,430	-211 Reduced 1.83%	11,331 $3.41 Million
Q3 2018 Oct 03, 2018	BUY	$293.51 - $383.83 $18,491 - $24,181	63 Added 0.55%	11,542 $4.08 Million
Q2 2018 Jul 06, 2018	BUY	$257.52 - $306.91 $223,784 - $266,704	869 Added 8.19%	11,479 $3.33 Million
Q1 2018 Apr 09, 2018	BUY	$260.13 - $367.91 $125,122 - $176,964	481 Added 4.75%	10,610 $2.91 Million
Q4 2017 Jan 11, 2018	BUY	$307.64 - $344.58 $3.12 Million - $3.49 Million	10,129	10,129 $3.23 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of First American Trust, Fsb, based on Form 13F filings with the SEC.

Stay updated on First American Trust, Fsb with notifications on news.